- Home
- CLNN vs NRXS Comparison
CLNN vs NRXS Comparison
Compare CLNN & NRXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLNN
- NRXS
- Stock Information
- Founded
- CLNN 2012
- NRXS 2011
- Country
- CLNN United States
- NRXS United States
- Employees
- CLNN N/A
- NRXS N/A
- Industry
- CLNN Biotechnology: Pharmaceutical Preparations
- NRXS
- Sector
- CLNN Health Care
- NRXS
- Exchange
- CLNN Nasdaq
- NRXS Nasdaq
- Market Cap
- CLNN 23.1M
- NRXS 25.0M
- IPO Year
- CLNN N/A
- NRXS 2023
- Fundamental
- Price
- CLNN $5.95
- NRXS $2.46
- Analyst Decision
- CLNN Strong Buy
- NRXS Strong Buy
- Analyst Count
- CLNN 5
- NRXS 1
- Target Price
- CLNN $33.00
- NRXS $7.00
- AVG Volume (30 Days)
- CLNN 101.0K
- NRXS 54.3K
- Earning Date
- CLNN 08-14-2025
- NRXS 08-12-2025
- Dividend Yield
- CLNN N/A
- NRXS N/A
- EPS Growth
- CLNN N/A
- NRXS N/A
- EPS
- CLNN N/A
- NRXS N/A
- Revenue
- CLNN $286,000.00
- NRXS $3,217,531.00
- Revenue This Year
- CLNN N/A
- NRXS $62.14
- Revenue Next Year
- CLNN $2,178.18
- NRXS $131.87
- P/E Ratio
- CLNN N/A
- NRXS N/A
- Revenue Growth
- CLNN N/A
- NRXS 41.93
- 52 Week Low
- CLNN $2.28
- NRXS $1.33
- 52 Week High
- CLNN $6.90
- NRXS $6.20
- Technical
- Relative Strength Index (RSI)
- CLNN 65.46
- NRXS 48.19
- Support Level
- CLNN $5.12
- NRXS $2.35
- Resistance Level
- CLNN $6.49
- NRXS $2.68
- Average True Range (ATR)
- CLNN 0.63
- NRXS 0.13
- MACD
- CLNN 0.10
- NRXS 0.02
- Stochastic Oscillator
- CLNN 81.76
- NRXS 49.07
About CLNN Clene Inc.
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.
About NRXS Neuraxis Inc.
Neuraxis Inc is a growth stage company is engaged in developing neuromodulation therapies to address chronic and debilitating conditions in children. The company is dedicated to advancing the science with its' proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology. The company focuses on targeted therapies for the pediatric and adolescent population suffering from disorders of gut-brain interaction (DGBIs).